PRESENTATION: Key challenges and lab solutions in your global cell and gene therapy trials

Dr. Maryland Franklin, VP and enterprise head of cell and gene therapy, led a special presentation in Singapore on strategies for cell and gene therapy (CGT) development. Her session highlights several challenges in the global CGT landscape and demonstrate how Labcorp is uniquely positioned to support biopharma partners' CGT products throughout the entire lifespan of development. With experience advancing all 6 FDA-approved CAR-T and 8 FDA-approved gene replacement therapies, we offer bespoke solutions for discovery, clinical trials, CMC testing, biomarkers and regulatory support. Download the presentation to learn more about our global CGT solutions.